The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Allopurinol is prescribed to treat gouty arthritis and prevent specific kidney stones by reducing high uric acid levels in the blood. Allopurinol (ALPURIC 100 TABLET) is a xanthine oxidase inhibitor, ...

If you’re looking at treatment options for certain conditions caused by high uric acid levels, you may want to learn more about allopurinol (Zyloprim, Aloprim). Allopurinol is a generic prescription ...

Allopurinol oral tablet is available as a generic drug and as brand-name drugs. Brand names: Zyloprim and Lopurin. Allopurinol is also given as an injection by a healthcare professional in the ...

Global pharma major Lupin Limited (Lupin) on Friday announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for ...

The Lupin stock surged by 2.86 per cent on the BSE, trading at ₹1,281.30 as of 10:20 am on Monday. The USFDA recently provided ANDA (Abbreviated New Drug Application) approval for its Allopurinol ...

New Delhi, Oct 14 (PTI) Drug firm Zydus Cadila today said it has received final approval from the US health regulator to market Allopurinol tablets used for treatment of patients with gout and other ...

Allopurinol use is not associated with renal function decline among those with newly diagnosed gout. HealthDay News — For patients with gout, allopurinol is associated with a reduced risk for ...

The Lupin stock was trading higher by 2.93 per cent, or Rs 36.50, at Rs 1282.15 at 9:38 am on Monday. The company's market cap at the time of writing this news stood at Rs 58,322.45 crore. "Global ...

Share price of Cadila Healthcare rose 1 percent intraday Monday on USFDA approval for Allopurinol tablets. Zydus Cadila has received final approval from the USFDA to market Allopurinol Tablets USP, ...